Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 176,207 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Follow-Up Questions
What is Fresenius SE & Co KGaA (FSNUY)'s P/E Ratio?
The P/E ratio of Fresenius SE & Co KGaA is N/A
What is the price performance of FSNUY stock?
The current price of FSNUY is 13.95, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Fresenius SE & Co KGaA?
Fresenius SE & Co KGaA belongs to Health Care industry and the sector is Health Care
What is Fresenius SE & Co KGaA market cap?
Fresenius SE & Co KGaA's current market cap is $31.4
Is Fresenius SE & Co KGaA a buy, sell, or hold?
According to wall street analysts, 21 analysts have made analyst ratings for Fresenius SE & Co KGaA, including 9 strong buy, 11 buy, 3 hold, 0 sell, and 9 strong sell
